1. Home
  2. STNG vs ICUI Comparison

STNG vs ICUI Comparison

Compare STNG & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scorpio Tankers Inc.

STNG

Scorpio Tankers Inc.

HOLD

Current Price

$51.26

Market Cap

3.2B

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$146.05

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STNG
ICUI
Founded
2009
1984
Country
Monaco
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.2B
IPO Year
2010
1992

Fundamental Metrics

Financial Performance
Metric
STNG
ICUI
Price
$51.26
$146.05
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$69.20
$179.50
AVG Volume (30 Days)
1.2M
255.7K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
3.28%
N/A
EPS Growth
N/A
N/A
EPS
5.88
N/A
Revenue
$889,539,000.00
$2,320,363,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.54
N/A
P/E Ratio
$8.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.63
$107.00
52 Week High
$65.52
$175.51

Technical Indicators

Market Signals
Indicator
STNG
ICUI
Relative Strength Index (RSI) 26.55 59.51
Support Level $51.14 $145.32
Resistance Level $52.38 $148.95
Average True Range (ATR) 1.30 4.01
MACD -0.42 -0.63
Stochastic Oscillator 8.92 65.40

Price Performance

Historical Comparison
STNG
ICUI

About STNG Scorpio Tankers Inc.

Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owned, lease financed, or chartered in vessels spanning three different vessel segments Handymax, MR, and LR2. The company's fleet of tankers is the eco-friendly, and newest fleet on the water hauling clean petroleum products. It provides seaborne transportation of crude oil and refined petroleum products. The company generates the majority of its revenue from LR2.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: